It combines information on characteristics, utilization of care services, disease progression, and behaviors of people diagnosed with HIV infection.
CDC funds and assists state and local health departments to collect the information and report data to CDC after personal identifiers are removed.
CDC conducted a meta-analysis of behavioral data from national surveys to estimate the number of persons in the U. who have injected drugs to use as a denominator to calculate HIV diagnosis and prevalence rates for IDU.
National estimates of population sizes can be used to provide a broader understanding of the HIV epidemic among those at risk for transmission and acquisition of HIV.
The terms do not indicate when the people were infected, but rather, when they were diagnosed.
CDC’S National HIV Surveillance System is the primary source for monitoring HIV trends in the United States.
Information from around the country can be analyzed to determine who is being affected and is essential for monitoring whether people are receiving the vital HIV medical care services they need to live long, healthy lives and reduce transmission to others.
Data from NHSS on HIV infection among persons who inject drugs is disseminated through national HIV/AIDS surveillance reports, surveillance slide sets, the National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention (NCHHSTP) Atlas , and other sources for a wide range of uses at the federal, state, and local levels.